ALFA FinderBSE filing, NSE: ENNATURE. Summary written from the filing by ALFA Finder's alert engine.
Ennature Bio Pharma Ltd: key numbers
- Share price
- ₹196.95
- Market cap
- ₹440.0 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹0.00 Cr
- Promoter holding
- 59.63%
- FII holding
- 2.44%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ennature Bio Pharma Ltd
All →Ennature Bio Pharma Board Meeting Outcome
Ennature Bio Pharma's board approved adoption of new Articles of Association to align with SCRA Rules 1957 and group governance. The change is subject to shareholder approval.
Ennature Bio Pharma Q2 FY27 Results: Turns Profitable, Net Profit ₹4.9 Cr
Ennature Bio Pharma Ltd reported revenue from operations of ₹78.5 Cr (+45.1% YoY) and net profit of ₹4.9 Cr for Q2 FY27.
- Key figure
- Net profit ₹4.9 Cr
Ennature Bio Pharma Board Meeting Date
Ennature Bio Pharma will hold a board meeting on 12 November 2026 to consider unaudited second-quarter results ended September 2026. Trading window stays closed until 14 November.
Ennature Bio Pharma Capital Structure Change
Ennature Bio Pharma listed its equity shares on NSE and BSE on 4 November 2026. The company brings its API, biopolymer and nutraceutical businesses to public markets.
Other other announcement announcements
All →Sri Nachammai Cotton Mills Other Announcement
Sri Nachammai Cotton Mills filed its half-yearly related party transaction report for the period ended 30 Sept 2026. This is a routine regulatory disclosure with no new transaction or business decision.
Bajaj Consumer Care Other Announcement
Bajaj Consumer Care informs exchanges that its RTA KFin Technologies is relocating its Hyderabad office effective December 1, 2026. No financial or business impact is involved.
Rentomojo Other Announcement
Rentomojo filed its Crisil Monitoring Agency Report for the quarter ended September 30, 2026 on IPO-proceeds utilisation. No deviation from the offer objects was reported.
Suraj Industries Other Announcement
Suraj Industries filed its quarterly Monitoring Agency report for the Rights Issue under Regulation 32(6). Acuté Ratings found no deviation in utilisation of the issue proceeds.
Triveni Glass Other Announcement
Triveni Glass director Anil Kumar Dhawan bought 15,188 shares on BSE for Rs.1,43,992. Routine PIT Reg 7(2) disclosure by a non-promoter director.
- Value
- ₹0.01 Cr
GRE Renew Enertech Other Announcement
GRE Renew Enertech filed its Reg 32 quarterly statement on IPO proceeds utilisation. It reports a reallocation of funds from solar plant capex to general corporate purposes.